SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.240+2.5%Dec 19 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Straynut who wrote (12722)4/15/2020 2:27:34 AM
From: HardToFind  Read Replies (1) of 12873
 
The company recently developed antiviral drug testing assays and acquired two low-threat circulating coronaviruses to test its SARS-CoV-2 drug candidates in its BSL-2 lab.
This in-house testing doesn't require USAMRIID. Do you have any idea how long would it take to get in-vitro results on those two low-threat circulating coronaviruses?

I seem to recall that Brian has been able to turn around informal results in as little as a few weeks. Is that right?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News